Hepatocellular Carcinoma Identification Using Delta-HLD

Clinical trial NCT07148310 · RECRUITING

Trial details

NCT number: NCT07148310
Sponsor: Epiliquid Holding, Inc
Status: RECRUITING
Study type: OBSERVATIONAL

Hepato Cellular Carcinoma (HCC)

Start date: 2023-05-18
Primary completion: 2026-08-12
Enrollment: 200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.